-DOCSTART- -X- O
Manufacturing -X- _ O
of -X- _ O
cell -X- _ B-Intervention
culture-derived -X- _ I-Intervention
virus -X- _ I-Intervention
particles -X- _ I-Intervention
for -X- _ I-Intervention
vaccination -X- _ I-Intervention
and -X- _ I-Intervention
gene -X- _ I-Intervention
therapy -X- _ I-Intervention
is -X- _ O
a -X- _ O
rapidly -X- _ O
growing -X- _ O
field -X- _ O
in -X- _ O
the -X- _ O
biopharmaceutical -X- _ O
industry. -X- _ O
The -X- _ O
process -X- _ O
involves -X- _ O
a -X- _ O
number -X- _ O
of -X- _ O
complex -X- _ O
tasks -X- _ O
and -X- _ O
unit -X- _ O
operations -X- _ O
ranging -X- _ O
from -X- _ O
selection -X- _ O
of -X- _ O
host -X- _ O
cells -X- _ O
and -X- _ O
virus -X- _ O
strains -X- _ O
for -X- _ O
the -X- _ O
cultivation -X- _ O
in -X- _ O
bioreactors -X- _ O
to -X- _ O
the -X- _ O
purification -X- _ O
and -X- _ O
formulation -X- _ O
of -X- _ O
the -X- _ O
final -X- _ O
product. -X- _ O
For -X- _ O
the -X- _ O
majority -X- _ O
of -X- _ O
cell -X- _ O
culture-derived -X- _ O
products -X- _ O
, -X- _ O
efforts -X- _ O
focused -X- _ O
on -X- _ O
maximization -X- _ O
of -X- _ O
bioreactor -X- _ O
yields -X- _ O
, -X- _ O
whereas -X- _ O
design -X- _ O
and -X- _ O
optimization -X- _ O
of -X- _ O
downstream -X- _ O
processes -X- _ O
were -X- _ O
often -X- _ O
neglected. -X- _ O
Owing -X- _ O
to -X- _ O
this -X- _ O
biased -X- _ O
focus -X- _ O
, -X- _ O
downstream -X- _ O
procedures -X- _ O
today -X- _ O
often -X- _ O
constitute -X- _ B-Outcome
a -X- _ I-Outcome
bottleneck -X- _ I-Outcome
in -X- _ I-Outcome
various -X- _ I-Outcome
manufacturing -X- _ I-Outcome
processes -X- _ I-Outcome
and -X- _ I-Outcome
account -X- _ I-Outcome
for -X- _ I-Outcome
the -X- _ I-Outcome
majority -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
overall -X- _ I-Outcome
production -X- _ I-Outcome
costs. -X- _ I-Outcome
For -X- _ O
efficient -X- _ O
production -X- _ O
methods -X- _ O
, -X- _ O
particularly -X- _ O
in -X- _ O
sight -X- _ O
of -X- _ O
constantly -X- _ O
increasing -X- _ O
economic -X- _ O
pressure -X- _ O
within -X- _ O
human -X- _ O
healthcare -X- _ O
systems -X- _ O
, -X- _ O
highly -X- _ O
productive -X- _ O
downstream -X- _ O
schemes -X- _ O
have -X- _ O
to -X- _ O
be -X- _ O
developed. -X- _ O
Here -X- _ O
, -X- _ O
we -X- _ O
discuss -X- _ O
unit -X- _ O
operations -X- _ O
and -X- _ O
downstream -X- _ O
trains -X- _ O
to -X- _ O
purify -X- _ O
virus -X- _ O
particles -X- _ O
for -X- _ O
use -X- _ O
as -X- _ O
vaccines -X- _ O
and -X- _ O
vectors -X- _ O
for -X- _ O
gene -X- _ O
therapy -X- _ O
. -X- _ O

